Penumbra, Inc.(PEN)Earnings, Financials & Key Ratios

PEN•NYSE

$324.19

$12.75B mkt cap·71.7× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryNeuromodulation and neuro devices

AboutPenumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.Show more

Revenue$1.4B+17.5%
EBITDA$207M+526.8%
Net Income$178M+1168.1%
EPS (Diluted)4.52+1155.6%
Gross Margin67.14%+6.2%
EBITDA Margin14.73%+433.4%
Operating Margin13.48%+1635.9%
Net Margin12.66%+979.3%
ROE13.78%+1045.8%
ROIC11.31%+1765.1%
Debt/Equity0.15-20.7%

Analysis→Technical→

PEN Key Insights

Penumbra, Inc. (PEN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 20.2%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

PEN Price & Volume

Penumbra, Inc. (PEN) stock price & volume — 10-year historical chart

Loading chart...

PEN Growth Metrics

Penumbra, Inc. (PEN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years22.39%

5 Years20.16%

3 Years18.33%

TTM17.27%

Profit CAGR

10 Years54.02%

5 Years-

3 Years-

TTM305.01%

EPS CAGR

10 Years49.69%

5 Years-

3 Years-

TTM309.43%

Return on Capital

10 Years2.14%

5 Years3.7%

3 Years6.27%

Last Year12.54%

PEN Recent Earnings

Penumbra, Inc. (PEN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 11/12 qtrs (92%)●Beat Revenue 8/12 qtrs (67%)

Q1 2026Latest

Feb 25, 2026

EPS

$1.18

Est $1.11

+6.3%

Revenue

$385M

Est $362M

+6.5%

Q4 2025

Nov 5, 2025

EPS

$0.97

Est $0.93

+4.4%

Revenue

$355M

Est $341M

+4.0%

Q3 2025

Jul 29, 2025

EPS

$0.86

Est $0.81

+6.2%

Revenue

$339M

Est $341M

-0.6%

Q2 2025

Apr 23, 2025

EPS

$0.83

Est $0.66

+25.8%

Revenue

$324M

Est $327M

-1.0%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 25, 2026	$1.18vs $1.11+6.3%	$385Mvs $362M+6.5%
Q4 2025	Nov 5, 2025	$0.97vs $0.93+4.4%	$355Mvs $341M+4.0%
Q3 2025	Jul 29, 2025	$0.86vs $0.81+6.2%	$339Mvs $341M-0.6%
Q2 2025	Apr 23, 2025	$0.83vs $0.66+25.8%	$324Mvs $327M-1.0%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
ISRGIntuitive Surgical, Inc.Direct Competitor	160.44B	451.73	57.40	20.51%	28.15%	16.89%	0.02
NVCRNovoCure LimitedDirect Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
NVSTEnvista Holdings CorpDirect Competitor	4.5B	27.06	96.64	8.32%	2.41%	2.18%	0.55
INVAInnoviva, Inc.Direct Competitor	1.91B	22.52	6.82	18.52%	118.91%	46.47%	0.23
SYKStryker CorporationProduct Competitor	111.96B	292.33	34.80	11.16%	12.92%	15.04%	0.66
BSXBoston Scientific CorporationProduct Competitor	83.23B	56.00	28.87	19.87%	14.4%	12.4%	0.51
MDTMedtronic plcProduct Competitor	99.48B	77.60	21.50	3.62%	13%	9.45%	0.59
EWEdwards Lifesciences CorporationProduct Competitor	47.97B	83.20	45.46	11.55%	17.64%	10.35%	0.07

Compare PEN vs Peers

Penumbra, Inc. (PEN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ISRG

Most directly comparable listed peer for PEN.

Scale Benchmark

vs SYK

Larger-name benchmark to compare PEN against a more recognizable public peer.

Peer Set

Compare Top 5

vs ISRG, NVCR, NVST, INVA

PEN Income Statement

Penumbra, Inc. (PEN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	333.76M	444.94M	547.4M	560.41M	747.59M	847.13M	1.06B	1.19B	1.4B	1.45B
Revenue Growth %	26.75%	33.31%	23.03%	2.38%	33.4%	13.32%	24.95%	12.86%	17.5%	17.27%
Cost of Goods Sold	116.62M	152.41M	175.44M	222.24M	272.21M	311.93M	375.88M	439.62M	461.23M	474.32M
COGS % of Revenue	34.94%	34.25%	32.05%	39.66%	36.41%	36.82%	35.51%	36.8%	32.86%	-
Gross Profit	217.14M▲ 0%	292.53M▲ 34.7%	371.96M▲ 27.2%	338.18M▼ 9.1%	475.38M▲ 40.6%	535.21M▲ 12.6%	682.64M▲ 27.5%	755M▲ 10.6%	942.44M▲ 24.8%	979.97M▲ 0%
Gross Margin %	65.06%	65.75%	67.95%	60.34%	63.59%	63.18%	64.49%	63.2%	67.14%	67.38%
Gross Profit Growth %	27.11%	34.72%	27.15%	-9.08%	40.57%	12.58%	27.55%	10.6%	24.83%	-
Operating Expenses	215.98M	293.38M	324.46M	377.12M	482.88M	529.13M	609.09M	745.72M	753.19M	792.83M
OpEx % of Revenue	64.71%	65.94%	59.27%	67.29%	64.59%	62.46%	57.54%	62.42%	53.66%	-
Selling, General & Admin	184.32M	226.38M	272.73M	287.07M	378.33M	449.72M	506.45M	573.99M	663.42M	702.76M
SG&A % of Revenue	55.22%	50.88%	49.82%	51.22%	50.61%	53.09%	47.85%	48.05%	47.26%	-
Research & Development	31.66M	36.16M	51.72M	90.05M	104.55M	79.41M	84.42M	94.78M	89.77M	90.07M
R&D % of Revenue	9.49%	8.13%	9.45%	16.07%	13.99%	9.37%	7.98%	7.93%	6.4%	-
Other Operating Expenses	0	30.84M	0	0	0	0	18.21M	76.94M	0	0
Operating Income	1.17M▲ 0%	-852K▼ 173.1%	47.51M▲ 5676.1%	-38.94M▼ 182.0%	-7.5M▲ 80.7%	6.08M▲ 181.1%	73.55M▲ 1109.3%	9.28M▼ 87.4%	189.25M▲ 1939.5%	187.13M▲ 0%
Operating Margin %	0.35%	-0.19%	8.68%	-6.95%	-1%	0.72%	6.95%	0.78%	13.48%	12.87%
Operating Income Growth %	186.3%	-173.13%	5676.06%	-181.97%	80.74%	181.08%	1109.32%	-87.38%	1939.54%	-
EBITDA	4.95M	5.32M	55.61M	-26.05M	8.91M	30.4M	100.81M	32.98M	206.72M	199.59M
EBITDA Margin %	1.48%	1.19%	10.16%	-4.65%	1.19%	3.59%	9.52%	2.76%	14.73%	13.72%
EBITDA Growth %	422.28%	7.48%	946.12%	-146.84%	134.19%	241.34%	231.57%	-67.28%	526.79%	239.86%
D&A (Non-Cash Add-back)	3.78M	6.17M	8.1M	12.89M	16.41M	24.32M	27.26M	23.7M	17.47M	12.46M
EBIT	1.17M	29.98M	47.51M	-38.94M	-8.57M	5.64M	81.39M	22.29M	205.13M	161.92M
Net Interest Income	2.65M	2.96M	2.85M	1.27M	938K	137K	5.09M	12.27M	0	7.69M
Interest Income	2.65M	2.96M	2.85M	1.27M	2.87M	1.89M	6.83M	13.69M	0	8.35M
Interest Expense	0	0	0	0	1.93M	1.75M	1.74M	1.42M	0	657K
Other Income/Expense	1.31M	2.46M	2.63M	924K	-3M	-2.19M	6.1M	11.59M	15.88M	15.82M
Pretax Income	2.48M▲ 0%	1.61M▼ 35.1%	50.13M▲ 3017.8%	-38.02M▼ 175.8%	-10.5M▲ 72.4%	3.89M▲ 137.1%	79.65M▲ 1946.5%	20.87M▼ 73.8%	205.13M▲ 882.9%	202.96M▲ 0%
Pretax Margin %	0.74%	0.36%	9.16%	-6.78%	-1.4%	0.46%	7.52%	1.75%	14.61%	13.96%
Income Tax	-3.61M	-4.4M	3.13M	-18.76M	-13.13M	5.89M	-11.3M	6.86M	27.44M	31.91M
Effective Tax Rate %	-145.84%	-273.82%	6.25%	49.35%	124.98%	151.44%	-14.19%	32.86%	13.38%	15.72%
Net Income	4.66M▲ 0%	6.6M▲ 41.7%	48.46M▲ 634.1%	-15.7M▼ 132.4%	5.28M▲ 133.7%	-2M▼ 137.9%	90.95M▲ 4643.2%	14.01M▼ 84.6%	177.69M▲ 1168.1%	171.05M▲ 0%
Net Margin %	1.4%	1.48%	8.85%	-2.8%	0.71%	-0.24%	8.59%	1.17%	12.66%	11.76%
Net Income Growth %	-68.56%	41.74%	634.1%	-132.4%	133.65%	-137.89%	4643.16%	-84.59%	1168.11%	305.01%
Net Income (Continuing)	6.09M	6.01M	47M	-19.26M	2.62M	-2M	90.95M	14.01M	177.69M	171.05M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	175K	-279K	-3.71M	0	0	0	0	0	0
EPS (Diluted)	0.13▲ 0%	0.18▲ 38.5%	1.34▲ 644.4%	-0.54▼ 140.3%	0.14▲ 125.9%	-0.05▼ 137.8%	2.32▲ 4485.6%	0.36▼ 84.5%	4.52▲ 1155.6%	4.33▲ 0%
EPS Growth %	-70.45%	38.46%	644.44%	-140.3%	125.93%	-137.79%	4485.63%	-84.48%	1155.56%	309.43%
EPS (Basic)	0.14	0.18	1.39	-0.54	0.14	-0.05	2.37	0.36	4.57	-
Diluted Shares Outstanding	35.32M	36.09M	36.27M	35.77M	37.88M	37.84M	39.22M	39.27M	39.29M	39.54M
Basic Shares Outstanding	32.98M	36.09M	34.75M	35.77M	36.76M	37.84M	38.4M	38.63M	38.92M	39.28M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

PEN Balance Sheet

Penumbra, Inc. (PEN) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	382.23M	410.73M	463.13M	617.7M	681.47M	755.7M	915.4M	951.13M	1.22B	1.28B
Cash & Short-Term Investments	214.59M	200.89M	189.39M	264.83M	254.88M	188.03M	289.19M	340.13M	186.9M	241.29M
Cash Only	50.64M	67.85M	72.78M	69.67M	59.38M	69.86M	167.49M	324.4M	186.9M	241.29M
Short-Term Investments	163.95M	133.04M	116.61M	195.16M	195.5M	118.17M	121.7M	15.73M	0	0
Accounts Receivable	58.01M	81.9M	105.9M	114.61M	133.94M	203.38M	201.77M	167.67M	190.02M	183.29M
Days Sales Outstanding	63.44	67.18	70.61	74.64	65.39	87.63	69.57	51.23	49.41	45.95
Inventory	94.9M	115.74M	152.99M	219.53M	263.5M	334.01M	388.02M	406.74M	431.55M	438.54M
Days Inventory Outstanding	297.02	277.19	318.3	360.55	353.33	390.84	376.79	337.7	341.51	332.84
Other Current Assets	0	0	0	0	0	30.28M	36.42M	36.59M	408.22M	412.28M
Total Non-Current Assets	94.43M	104.28M	202.77M	205.28M	562.78M	615.19M	640.9M	582.06M	609.84M	623.03M
Property, Plant & Equipment	30.9M	35.41M	135.45M	127.43M	227.09M	280.41M	280.5M	268.45M	317M	329.54M
Fixed Asset Turnover	10.80x	12.57x	4.04x	4.40x	3.29x	3.02x	3.77x	4.45x	4.43x	4.74x
Goodwill	8.18M	7.81M	7.66M	8.37M	166.39M	166.05M	166.27M	165.83M	166.75M	166.59M
Intangible Assets	23.78M	27.25M	25.41M	10.64M	90.62M	91.72M	83.09M	6.51M	6.19M	5.95M
Long-Term Investments	3.87M	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	1.02M	875K	2.95M	8.71M	12.98M	12.79M	25.88M	141.27M	119.9M	321.27M
Total Assets	476.67M▲ 0%	515.01M▲ 8.0%	665.9M▲ 29.3%	822.98M▲ 23.6%	1.24B▲ 51.2%	1.37B▲ 10.2%	1.56B▲ 13.5%	1.53B▼ 1.5%	1.83B▲ 19.1%	1.9B▲ 0%
Asset Turnover	0.70x	0.86x	0.82x	0.68x	0.60x	0.62x	0.68x	0.78x	0.77x	0.81x
Asset Growth %	54.63%	8.04%	29.3%	23.59%	51.19%	10.18%	13.53%	-1.49%	19.13%	65.36%
Total Current Liabilities	51.58M	66.06M	91.05M	105.93M	123.2M	144.93M	151.14M	158.34M	183.13M	211.73M
Accounts Payable	6.76M	8.18M	15.11M	14.11M	13.42M	26.68M	27.16M	31.33M	34.74M	43.66M
Days Payables Outstanding	21.15	19.58	31.44	23.17	18	31.22	26.37	26.01	27.49	26.23
Short-Term Debt	0	0	0	0	0	0	0	0	16.23M	16.53M
Deferred Revenue (Current)	0	0	0	0	0	9.16M	6.99M	0	0	0
Other Current Liabilities	8.88M	9.3M	1.82M	9.81M	0	0	0	112.43M	132.16M	195.2M
Current Ratio	7.41x	6.22x	5.09x	5.83x	5.53x	5.21x	6.06x	6.01x	6.64x	6.64x
Quick Ratio	5.57x	4.47x	3.41x	3.76x	3.39x	2.91x	3.49x	3.44x	4.29x	4.29x
Cash Conversion Cycle	339.31	324.79	357.47	412.02	400.73	447.25	420	362.92	363.44	352.55
Total Non-Current Liabilities	24.68M	26.53M	89.24M	79.26M	167.13M	227.1M	226.22M	223.91M	215.78M	212.9M
Long-Term Debt	0	0	0	0	0	0	0	0	203.47M	199.65M
Capital Lease Obligations	0	0	73.99M	71.25M	163.57M	223.82M	220.91M	208.8M	0	406.81M
Deferred Tax Liabilities	3.3M	4.17M	4M	4.78M	0	0	0	0	0	0
Other Non-Current Liabilities	21.38M	22.36M	11.24M	3.23M	3.56M	3.28M	5.31M	15.11M	12.32M	57.92M
Total Liabilities	76.26M	92.59M	180.29M	185.19M	290.32M	372.03M	377.36M	382.25M	398.92M	424.63M
Total Debt	0	0	82.3M	77.28M	173.55M	235.77M	234.34M	223.39M	219.7M	216.18M
Net Debt	-50.64M	-67.85M	9.52M	7.61M	114.17M	165.91M	66.86M	-101.02M	32.8M	-25.11M
Debt / Equity	-	-	0.17x	0.12x	0.18x	0.24x	0.20x	0.19x	0.15x	0.15x
Debt / EBITDA	-	-	1.48x	-	19.48x	7.75x	2.32x	6.77x	1.06x	1.08x
Net Debt / EBITDA	-10.24x	-12.76x	0.17x	-	12.82x	5.46x	0.66x	-3.06x	0.16x	0.16x
Interest Coverage	-	-	-	-	-4.43x	3.23x	46.80x	15.72x	-	246.46x
Total Equity	400.41M▲ 0%	422.42M▲ 5.5%	485.61M▲ 15.0%	637.79M▲ 31.3%	953.93M▲ 49.6%	998.86M▲ 4.7%	1.18B▲ 18.0%	1.15B▼ 2.4%	1.43B▲ 24.0%	1.47B▲ 0%
Equity Growth %	50.22%	5.5%	14.96%	31.34%	49.57%	4.71%	18.03%	-2.38%	24.04%	80.02%
Book Value per Share	11.34	11.71	13.39	17.83	25.18	26.40	30.06	29.31	36.33	37.27
Total Shareholders' Equity	400.41M	422.24M	485.89M	641.5M	953.93M	998.86M	1.18B	1.15B	1.43B	1.47B
Common Stock	33K	34K	35K	36K	37K	38K	39K	38K	39K	39K
Retained Earnings	2M	9.06M	57.52M	40.62M	45.91M	43.9M	134.86M	60M	237.69M	270.27M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	1.57M	-1.94M	-2.32M	2.54M	-2.63M	-8.12M	-3.15M	-5.84M	4.35M	2.08M
Minority Interest	0	175K	-279K	-3.71M	0	0	0	0	0	0

PEN Cash Flow Statement

Penumbra, Inc. (PEN) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	12.69M	28.81M	26.65M	-33.24M	9.5M	-55.66M	97.33M	168.48M	238.66M	238.66M
Operating CF Margin %	3.8%	6.47%	4.87%	-5.93%	1.27%	-6.57%	9.2%	14.1%	17%	-
Operating CF Growth %	199.09%	127%	-7.48%	-224.73%	128.58%	-685.78%	274.87%	73.1%	41.66%	248.78%
Net Income	4.66M	2.91M	48.46M	-19.26M	5.28M	-2M	90.95M	14.01M	177.69M	171.05M
Depreciation & Amortization	3.78M	6.17M	7.85M	12.89M	19.49M	27.57M	30.61M	23.7M	17.47M	17.03M
Stock-Based Compensation	17.81M	18.42M	0	25.54M	0	0	0	46.16M	59.21M	60.07M
Deferred Taxes	-4.29M	-6.48M	1.82M	-18.82M	-14.09M	1.46M	-19.06M	-16.34M	21.03M	22.3M
Other Non-Cash Items	4.22M	38.05M	25.36M	17.59M	65.53M	38.84M	73.92M	124.72M	5.97M	216.62M
Working Capital Changes	-13.49M	-30.26M	-56.84M	-51.19M	-66.71M	-121.53M	-79.08M	-23.78M	-42.72M	-32.72M
Change in Receivables	-9.12M	-25.76M	-25.03M	-8.29M	-21.34M	-69.86M	-266K	26.6M	-19.51M	-14.52M
Change in Inventory	-18.83M	-22.29M	-41.41M	-56.98M	-51.55M	-74.63M	-67.71M	-65.66M	-26.48M	-14.09M
Change in Payables	1.85M	1.33M	6.04M	-308K	-1.56M	13.38M	1.1M	4.17M	3.07M	12.28M
Cash from Investing	-77.65M	-385K	-11.91M	-104.15M	-21.73M	54.79M	-16.08M	77.62M	-404.59M	-434.72M
Capital Expenditures	-15.03M	-9.6M	-22.11M	-24.76M	-21.18M	-19.3M	-15.21M	-21.18M	-63.73M	-63.93M
CapEx % of Revenue	4.5%	2.16%	4.04%	4.42%	2.83%	2.28%	1.44%	1.77%	4.54%	-
Acquisitions	-9.25M	-20.41M	800K	0	2.92M	0	-988K	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-55.87M	29.63M	-8.64M	-3.06M	-400K	0	-500K	1.1M	0	-1M
Cash from Financing	104.36M	-9.81M	-9.76M	134.92M	836K	11.62M	16.2M	-87.01M	26.53M	21.92M
Debt Issued (Net)	-1.08M	-404K	-2.57M	-3.42M	-1.45M	-1.75M	-1.98M	-2.28M	-2.48M	-1.87M
Equity Issued (Net)	106.27M	0	13.1M	134.76M	18.37M	21.55M	20.41M	-100.39M	31.82M	27.8M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	-17.73M	0	0	0	0	0	-100.39M	0	0
Other Financing	-829K	-9.41M	-20.29M	3.58M	-16.08M	-8.18M	-2.23M	15.66M	-2.8M	-4.01M
Net Change in Cash	37.4M▲ 0%	17.21M▼ 54.0%	4.93M▼ 71.4%	-3.11M▼ 163.1%	-10.29M▼ 231.0%	10.48M▲ 201.8%	97.63M▲ 831.7%	156.92M▲ 60.7%	-137.51M▼ 187.6%	-134.76M▲ 0%
Free Cash Flow	-2.34M▲ 0%	19.2M▲ 920.4%	4.54M▼ 76.3%	-58M▼ 1376.6%	-11.68M▲ 79.9%	-74.96M▼ 541.9%	82.12M▲ 209.6%	147.3M▲ 79.4%	174.93M▲ 18.8%	212.73M▲ 0%
FCF Margin %	-0.7%	4.32%	0.83%	-10.35%	-1.56%	-8.85%	7.76%	12.33%	12.46%	14.63%
FCF Growth %	91.15%	920.38%	-76.34%	-1376.65%	79.86%	-541.88%	209.55%	79.37%	18.76%	41.51%
FCF per Share	-0.07	0.53	0.13	-1.62	-0.31	-1.98	2.09	3.75	4.45	4.45
FCF Conversion (FCF/Net Income)	2.73x	4.36x	0.55x	2.12x	1.80x	27.80x	1.07x	12.02x	1.34x	1.24x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	141K	156K	0	1.41M	0	0	0	20.67M	0	7.08M

PEN Key Ratios

Penumbra, Inc. (PEN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	1.4%	1.6%	10.67%	-2.8%	0.66%	-0.21%	8.35%	1.2%	13.78%	12.32%
Return on Invested Capital (ROIC)	0.29%	-0.18%	8.39%	-5.12%	-0.66%	0.41%	4.58%	0.61%	11.31%	11.31%
Gross Margin	65.06%	65.75%	67.95%	60.34%	63.59%	63.18%	64.49%	63.2%	67.14%	67.38%
Net Margin	1.4%	1.48%	8.85%	-2.8%	0.71%	-0.24%	8.59%	1.17%	12.66%	11.76%
Debt / Equity	-	-	0.17x	0.12x	0.18x	0.24x	0.20x	0.19x	0.15x	0.15x
Interest Coverage	-	-	-	-	-4.43x	3.23x	46.80x	15.72x	-	246.46x
FCF Conversion	2.73x	4.36x	0.55x	2.12x	1.80x	27.80x	1.07x	12.02x	1.34x	1.24x
Revenue Growth	26.75%	33.31%	23.03%	2.38%	33.4%	13.32%	24.95%	12.86%	17.5%	17.27%

PEN SEC Filings & Documents

Penumbra, Inc. (PEN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 6, 2026·SEC

Material company update

Feb 25, 2026·SEC

Material company update

Jan 15, 2026·SEC

10-K Annual Reports

FY 2026

Feb 25, 2026·SEC

FY 2025

Feb 18, 2025·SEC

FY 2024

Feb 22, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 6, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Jul 29, 2025·SEC

PEN Frequently Asked Questions

Penumbra, Inc. (PEN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Penumbra, Inc. (PEN) reported $1.45B in revenue for fiscal year 2025. This represents a 1537% increase from $88.8M in 2013.

Penumbra, Inc. (PEN) grew revenue by 17.5% over the past year. This is strong growth.

Yes, Penumbra, Inc. (PEN) is profitable, generating $171.0M in net income for fiscal year 2025 (12.7% net margin).

Dividend & Returns

Penumbra, Inc. (PEN) has a return on equity (ROE) of 13.8%. This is reasonable for most industries.

Penumbra, Inc. (PEN) generated $212.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More PEN

Penumbra, Inc. (PEN) financial analysis — history, returns, DCA and operating performance tools

Full PEN Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Penumbra, Inc.(PEN)Earnings, Financials & Key Ratios

PEN Key Insights

✓Strengths

✗Weaknesses

PEN Price & Volume

PEN Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

PEN Recent Earnings

PEN Peer Comparison

Compare PEN vs Peers

vs ISRG

vs SYK

Compare Top 5

PEN Income Statement

PEN Balance Sheet

PEN Cash Flow Statement

PEN Key Ratios

PEN SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

PEN Frequently Asked Questions

Explore More PEN

Full PEN Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation